en.Wedoany.com Report on Mar 26th, The Board of Directors of Natco Pharma Ltd has approved a scheme to demerge its agrochemical business into its wholly-owned subsidiary, Natco Crop Health Sciences. This decision was made during a board meeting, aiming to optimize the operational structure and focus on core business areas.

According to the restructuring plan, existing shareholders of Natco Pharma will receive shares in the new company on a 1:1 basis to maintain their ownership stake in the agrochemical business. This demerger is expected to help streamline the company's operations while strengthening its focus on the pharmaceutical and crop protection sectors.

Additionally, the Hyderabad-based company has also approved a proposal to establish a wholly-owned subsidiary in Nigeria. The new entity will operate under the name Natco Pharma Nigeria, with an initial investment of $1 million. This move aims to enhance the company's international presence and tap into the growth potential of the African pharmaceutical market.

As part of ongoing corporate restructuring, the Board has also approved the liquidation of its wholly-owned subsidiary in Australia, Natco Pharma Australia Pty Ltd. These adjustments reflect the company's proactive approach to the agrochemical business demerger and its global strategy to adapt to the evolving market environment.